Direct visualization of fungal infection in brains from patients with Alzheimer's disease

Diana Pisa1, Ruth Alonso1, Angeles Juarranz2

  • 1Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.

Insights

Fungal infections are present in Alzheimer

Area of Science:

  • Neurology
  • Mycology
  • Infectious Diseases

Background:

  • Previous research indicated fungal presence in Alzheimer's disease (AD) brains.
  • Fungal proteins and DNA were previously detected in the central nervous system of AD patients.

Purpose of the Study:

  • To visualize fungal components within neurons of Alzheimer's disease patients.
  • To investigate the intracellular localization of fungi in the brain.

Main Methods:

  • Development of specific polyclonal antibodies against fungal species (e.g., Candida glabrata).
  • Immunohistochemistry and confocal microscopy on brain tissue from AD patients and infected mice.
  • Analysis of liver, spleen, and brain samples for fungal presence.

Main Results:

  • Immunopositive fungal material was detected intracellularly in ~10% of neurons from AD patients' frontal cortex.
  • Fungal components were observed in liver, spleen, and brain tissues of mice infected with Candida glabrata.
  • Absence of immunopositive material in control samples and uninfected mice.
  • Varied morphology of fungal material (disseminated or punctate bodies) observed within neurons.
  • Detection using multiple anti-fungal antibodies suggests potential for multiple fungal infections.

Conclusions:

  • Specific anti-fungal antibodies are crucial for detecting fungal infections in Alzheimer's disease brains.
  • Findings support the hypothesis that fungal cells are internalized within neurons in Alzheimer's disease.
  • This study offers a potential explanation for the previously elusive detection of fungi in AD brains.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
21
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19